|
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
|
5R21CA123855-02
|
$390,741
|
$390,741
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
#258 Preventing Adverse Effects of Radiotherapy with CBLB502
|
N43CO900028-000
|
$149,987
|
$49,496
|
Krivokrysenko, Vadim
|
Buffalo BioLabs, LLC
|
|
Identification of Hematopoietic Stem and Progenitor Cell Viability Genes
|
1R43CA141848-01
|
$249,465
|
$249,465
|
Bonneau, Kyle
|
CELLECTA, INC.
|
|
Pathophysiology of Post-Transplantation Cancer
|
1R01CA131145-01A2
|
$352,751
|
$352,751
|
Pal, Soumitro
|
CHILDREN'S HOSPITAL BOSTON
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-05
|
$318,664
|
$159,332
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Empirical Likelihood Bayes Analysis of Quantile Regression Model
|
1R03CA133944-01A2
|
$83,120
|
$41,560
|
Kim, Mi-Ok
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-05
|
$320,964
|
$160,482
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
5R01CA116660-03
|
$297,760
|
$297,760
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
CCNY/MSK Cancer Center Partnership, Training and Community Outreach
|
5U54CA132378-02
|
$1,630,014
|
$277,102
|
HUBBARD, KAREN
|
CITY COLLEGE OF NEW YORK
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
3P01CA030206-27S1
|
$76,071
|
$76,071
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
$269,958
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-27
|
$2,987,761
|
$2,987,761
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A Standardized Nursing Intervention Protocol for HCT Patients
|
5R01CA107446-04
|
$428,731
|
$428,731
|
GRANT, MARCIA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-22
|
$332,211
|
$3,322
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Antibody Targeted Radiation and Immunotherapy for the Treatment of Solid Tumors
|
5P01CA043904-18
|
$3,001,468
|
$900,440
|
RAUBITSCHEK, ANDREW
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Mechanisms of GVHD
|
9P01CA142106-06A1
|
$1,953,263
|
$1,953,263
|
ANTIN, JOSEPH
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
$3,736
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
$4,301
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
$350,667
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Ex Vivo Alloanergization to Improve Immunity After Haploidentical Transplant
|
1R21CA137645-01A1
|
$370,550
|
$370,550
|
GUINAN, EVA
|
DANA-FARBER CANCER INSTITUTE
|
|
GM-CSF secreting tumor cell vaccines to enhance post-transplant anti-CLL immunity
|
5R21CA132232-02
|
$378,360
|
$189,180
|
WU, CATHERINE
|
DANA-FARBER CANCER INSTITUTE
|
|
Novel Approaches to Stem Cell Transplantation
|
2P01CA047741-16A1
|
$1,827,050
|
$1,224,124
|
CHAO, NELSON
|
DUKE UNIVERSITY
|
|
Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
|
5R01CA132110-03
|
$297,920
|
$297,920
|
Szabolcs, Paul
|
DUKE UNIVERSITY
|
|
Novel Strategies for Cancer Immunotherapy in Stem Cell Transplant
|
1R01CA136934-01A1
|
$323,700
|
$323,700
|
YANG, YIPING
|
DUKE UNIVERSITY
|
|
Functions of E2A in B Lymphocyte Development
|
5R01CA072433-12
|
$310,291
|
$31,029
|
Zhuang, Yuan
|
DUKE UNIVERSITY
|
|
Family Decision Making in Pediatric Bone Marrow Transplant
|
5R21CA131875-02
|
$197,504
|
$197,504
|
PENTZ, REBECCA
|
EMORY UNIVERSITY
|
|
Facilitating Parent Adaptation to Pediatric Transplant: The P-SCIP Trial
|
5R01CA127488-02
|
$568,248
|
$568,248
|
MANNE, SHARON
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S1
|
$118,679
|
$5,934
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S2
|
$127,851
|
$6,393
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
3P30CA006927-47S3
|
$100,000
|
$5,000
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Comprehensive Cancer Center Program at Fox Chase
|
5P30CA006927-47
|
$8,241,288
|
$412,064
|
SEIDEN, MICHAEL
|
FOX CHASE CANCER CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-34
|
$5,273,382
|
$4,429,641
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
7R01CA112530-04
|
$501,100
|
$501,100
|
BAKER, KEVIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Career Development in Pediatric and Medical Oncology
|
2K12CA076930-11
|
$595,080
|
$297,540
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Pediaric Oncology Research Training Program
|
5T32CA009351-31
|
$223,195
|
$89,278
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
HPV: Biology, Clinical Significance and Epidemiology
|
5P01CA042792-21
|
$2,414,027
|
$1,207,014
|
GALLOWAY, DENISE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Immunosupression-Resistant Gene Modified Donor T Cells
|
5R01CA109381-05
|
$323,970
|
$323,970
|
GEORGES, GEORGE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
2P30CA015704-35
|
$10,977,925
|
$1,646,689
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S3
|
$249,999
|
$37,500
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S4
|
$85,601
|
$12,840
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-35S5
|
$100,000
|
$15,000
|
HARTWELL, LELAND
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Improving Outcomes Assessment in Chronic GVHD
|
5U01CA118953-03
|
$731,854
|
$731,854
|
LEE, STEPHANIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Clinical Significance of MHC Haplotypes in HCT
|
5R01CA100019-07
|
$344,520
|
$344,520
|
Petersdorf, Effie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Therapy of Lymphoma/Leukemia with Monoclonal Antibodies
|
5P01CA044991-22
|
$2,026,942
|
$1,216,165
|
Press, Oliver
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeted therapy of ALL with gene-modified central memory T cells
|
1R01CA136551-01A1
|
$551,563
|
$275,782
|
Riddell, Stanley
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Mixed Hematopoietic Chimerism After Stem Cell Allografts
|
2P01CA078902-11
|
$1,991,605
|
$1,832,277
|
STORB, RAINER
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Interdisciplinary Studies to Enhance Long Term Survival
|
5R01CA112631-05
|
$514,374
|
$514,374
|
SYRJALA, KAREN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Organ Transplantation Research for this search: $77,809,088
|